UNSPSC 51384524: Flurbiprofen sodium

This classification denotes a cyclooxygenase inhibitor and carbonic anhydrase inhibitor with the molecular formula C15H12FO2.Na.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z5B97MU9K4, chemically known as 4-biphenylacetic acid, 2-fluoro-alpha-methyl- but more generally known as flurbiprofen sodium, which bears US NIH Compound Identifier 3394. European Medicines Agency schedules Flurbiprofen sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02240MIG.

Most nations, for tariff and trade purposes, schedule flurbiprofen sodium under HS 29163900 and SITC 51379. As of Q4 2014, FLURBIPROFEN SODIUM remains US FDA's Preferred Term for this commodity. Flurbiprofen sodium bears US NLM identifiers UMLS ID C0304658 and NCI Concept Code C47997. SMILES: CC(C1CCC(C(C1)F)C2CCCCC2)C(=O)[O-].O.O.[NA+].

UNSPSC 51384524 Flurbiprofen sodium is a Commodity code that nominally covers a nonsteroidal anti-inflammatory pharmaceutical ingredient, but recent state and local procurement activity under this code shows a significant mismatch: Seminole County, Florida posted a competitive bid in June 2026 for naloxone and safe drug deactivation systems — opioid-reversal medication and harm-reduction equipment — which falls outside the flurbiprofen sodium scope. The county's solicitation (IFB60459723LAS, response due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, with vendors required to cover all shipping and delivery costs, maintain workers' compensation and commercial general liability insurance, and comply with E-Verify and drug-free workplace certification. The contract carries a two-year initial term with an optional one-year renewal and includes potential FEMA funding, which introduces Clean Air Act and Federal Water Pollution Control Act compliance obligations.

The code shows limited recent state and local activity, with only one identifiable opportunity in the available record. Seminole County's posting suggests procurement interest in community health and harm-reduction initiatives, but the misalignment between the nominal commodity classification and the actual work being solicited indicates that flurbiprofen sodium may not be a reliable categorization for state and local buyers pursuing pharmaceutical or medical-device contracts. Vendors evaluating this code should verify that solicitations they encounter are correctly tagged before committing bid resources, as the code's abstract definition does not align with the types of transactions currently posted under it in state and local procurement systems.